Public Population Health

At Deloitte, we are passionate about helping our clients deliver on their missions in a public health arena that is increasingly complex with regulatory, economic, social, and environmental challenges. Right now, we are collaborating with our clients to respond to the international Zika epidemic, to combat the opioid overdose crisis, to improve health services to our active duty military, their dependents, and our veterans, and to advance the cancer moonshot, just to name a few. Our talented team of policy, research, evaluation, and other health consultants are committed to bringing our experiences to address key public health challenges.

At Deloitte, we are applying targeted marketing and partnership engagement approaches to facilitate behavior change for those at risk for diabetes and diabetes-related secondary conditions. Our public health and health communications professionals are combining social marketing principles with strategic engagement and partnership management to influence individuals’ access to and choices around diabetes prevention interventions.

Read more on Turning the tide on diabetes management

At Deloitte, we’re committed to efficient, intelligent responses to public health outbreaks. We are collaborating across US government agencies to accelerate Zika vaccine development and improve cross-agency portfolio management and communication. Our dedicated professionals bring together pre-clinical, clinical, regulatory, manufacturing, and commercial perspectives to help the US government respond to the Zika epidemic and develop a model to more quickly respond to future public health challenges.

At Deloitte, we’re working with federal, state, and local public health agencies to understand and address the myriad challenges of opioid use and misuse. From helping our clients to re-envision the strategy for nationwide surveillance of prescription drug monitoring data, to optimizing national advocacy strategies at the state and local levels, Deloitte practitioners are on the cutting-edge of stemming the epidemic. We are engaging new partners in the fight against opioid abuse and aligning action across the public health ecosystem to generate a powerful, coordinated response to opioid overdose.

Learn more about Solving the country’s opioid crisis.

Federal and state governments and NGOs take a variety of actions to promote healthy decisions and behaviors, enacting policies, laws, and regulations to help mitigate “unhealthy” choices and encourage “healthy” ones. At Deloitte, our consultants are applying principles of behavioral economics to our clients’ missions to improve the public’s health. Our talented team of policy, research, evaluation, actuarial, and health economic specialists are committed to developing evidence-based “nudges” that help individuals, groups, and communities to make more healthful choices and create more healthy environments.

Read more on How behavioral factors create influential health campaigns

Read more on Fusing mobile technologies with behavioral science to improve health outcomes

Read more on You snooze, you win: Why organizations should prioritize having a well-rested workforce

At Deloitte, we know public health stakeholders are stretching their dollars to do more with less. Our financial analysts and actuarial practitioners help public health organizations create innovative financing mechanisms to get more out of their resources. We can support your budget planning models to better coordinate funding streams for public.

Read more on Driving impact for Federal grant programs

Read more on Supporting healthy communities: How rethinking the funding approach can break down silos and promote health and health equity

Learn more about Deloitte Grants Management: Modernizing grants programs to increase efficiency and impact

Evaluating performance to produce actionable insights; at Deloitte, we can help you assess how well your program is working through process, impact, and outcome evaluation that encompasses data analytics, organizational assessment, and strategic change. Our evaluators provide in-depth examination of programmatic performance that supports policy decisions, resource allocations, and overall program effectiveness and efficacy. We can also help you comply with the federally mandated evaluation requirements.

Read more on How low-cost, lightweight randomized control trials (RCTs) can improve program evaluation

Presenting research results to non-technical audiences poses unique challenges to simultaneously make results clear and actionable. At Deloitte, we employ advance data visualization techniques to help convey important public health information to policy makers. Deloitte’s Survey Research and Analytics Center completed the 2014-2015 Health Related Behaviors Survey of Active Duty Personnel for the Defense Health Agency’s Decision Support Center. We analyzed survey results from nearly 46,000 active duty personnel on a variety of health-related behavioral topics, and used innovative data visualization approaches to present actionable and impactful results to military leadership help shape their future health policy.

Read more on Rising consumerism: Winning the hearts and minds of health care consumers.

Read more on The healthy choice: How behavioral factors create influential health campaigns